A Prospective, Observational Study to Evaluate the Safety and Feasibility of Continuous Renal Replacement Therapy With Regional Citrate Anticoagulation in a Cohort Critical Ill Patients With Acute Kidney Injury and Presumed Absent Citrate Metabolism

Sponsor
University Hospital, Antwerp
Study ID
NCT07751874
Status
Not Yet Recruiting

Notify me when recruiting opens

Save your spot on the interest list for this study. We'll keep your details with this study so our team can follow up when recruiting opens.

Not yet recruiting

Add your contact details and location so we can keep your interest tied to this study.

Conditions

  • Acute Kidney Injury

Eligibility Criteria

Sex
ALL
Age
18 Years - N/A
Healthy Volunteers
Not accepted

Interventions

  • continuous renal replacement therapy with regional citrate anticoagulation — DEVICE
    CVVHDF using regional citrate anticoagulation in patients with absent or reduced citrate metabolism

Study Details

Use of regional citrate anticoagulation in an at risk population with decreased citrate metabolism. This study assesses the feasibility and safety of regional citrate anticoagulation in this population.

Key Dates

First listed
Aug 7, 2026
Start date
Oct 15, 2026
Status verified
Aug 2026
Primary completion
Jan 1, 2028
Completion
Jul 1, 2028

Study Design

Enrollment
50 participants (estimated)

Arms

  • Arm: Citrate group
    Patients needing continuous renal replacement therapy with absent or reduced citrate metabolism treated with regional citrate anticoagulation

Primary Outcome Measure

the incidence of citrate intoxication [ Time Frame: 96 hours ]

Central Contacts

Related Studies